Cardiol Therapeutics Inc
TSX:CRDL

Watchlist Manager
Cardiol Therapeutics Inc Logo
Cardiol Therapeutics Inc
TSX:CRDL
Watchlist
Price: 1.47 CAD -2% Market Closed
Market Cap: 146.3m CAD

Intrinsic Value

The intrinsic value of one CRDL stock under the Base Case scenario is 2.8 CAD. Compared to the current market price of 1.47 CAD, Cardiol Therapeutics Inc is Undervalued by 47%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CRDL Intrinsic Value
2.8 CAD
Undervaluation 47%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Cardiol Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CRDL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CRDL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cardiol Therapeutics Inc.

Explain Valuation
Compare CRDL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CRDL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cardiol Therapeutics Inc

Current Assets 12.8m
Cash & Short-Term Investments 11.6m
Receivables 195.9k
Other Current Assets 988.5k
Non-Current Assets 141k
PP&E 141k
Current Liabilities 3.3m
Accounts Payable 3.3m
Other Current Liabilities 37k
Non-Current Liabilities 97.2k
Long-Term Debt 97.3k
Other Non-Current Liabilities -100
Efficiency

Free Cash Flow Analysis
Cardiol Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cardiol Therapeutics Inc

Revenue
0 CAD
Operating Expenses
-36.3m CAD
Operating Income
-36.3m CAD
Other Expenses
1.5m CAD
Net Income
-34.8m CAD
Fundamental Scores

CRDL Profitability Score
Profitability Due Diligence

Cardiol Therapeutics Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
47/100
Profitability
Score

Cardiol Therapeutics Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

CRDL Solvency Score
Solvency Due Diligence

Cardiol Therapeutics Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
67/100
Solvency
Score

Cardiol Therapeutics Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRDL Price Targets Summary
Cardiol Therapeutics Inc

There are no price targets for CRDL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cardiol Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CRDL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CRDL stock?

The intrinsic value of one CRDL stock under the Base Case scenario is 2.8 CAD.

Is CRDL stock undervalued or overvalued?

Compared to the current market price of 1.47 CAD, Cardiol Therapeutics Inc is Undervalued by 47%.

Back to Top